The Directors at GentiBio lead various critical functions across the organization to drive the company's mission of developing engineered regulatory T cells (EngTregs) for treating immune-related diseases. They oversee strategic initiatives in areas such as automation, informatics, IT, process and analytical development, pharmacology and toxicology, quality assurance, program management, technical development, translational sciences, and discovery. This team collaborates to integrate GentiBio's proprietary technologies and advance its therapeutic platforms toward clinical and commercial success.